185 related articles for article (PubMed ID: 11148800)
1. Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis.
Haguenauer D; Welch V; Shea B; Tugwell P; Adachi JD; Wells G
Osteoporos Int; 2000; 11(9):727-38. PubMed ID: 11148800
[TBL] [Abstract][Full Text] [Related]
2. Fluoride for treating postmenopausal osteoporosis.
Haguenauer D; Welch V; Shea B; Tugwell P; Wells G
Cochrane Database Syst Rev; 2000; 2000(4):CD002825. PubMed ID: 11034769
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
[TBL] [Abstract][Full Text] [Related]
4. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
[TBL] [Abstract][Full Text] [Related]
5. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
[TBL] [Abstract][Full Text] [Related]
6. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women.
Cranney A; Wells G; Willan A; Griffith L; Zytaruk N; Robinson V; Black D; Adachi J; Shea B; Tugwell P; Guyatt G;
Endocr Rev; 2002 Aug; 23(4):508-16. PubMed ID: 12202465
[TBL] [Abstract][Full Text] [Related]
7. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
9. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ
N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957
[TBL] [Abstract][Full Text] [Related]
10. Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate.
Ringe JD; Kipshoven C; Cöster A; Umbach R
Osteoporos Int; 1999; 9(2):171-8. PubMed ID: 10367046
[TBL] [Abstract][Full Text] [Related]
11. Exercise for preventing and treating osteoporosis in postmenopausal women.
Bonaiuti D; Shea B; Iovine R; Negrini S; Robinson V; Kemper HC; Wells G; Tugwell P; Cranney A
Cochrane Database Syst Rev; 2002; (3):CD000333. PubMed ID: 12137611
[TBL] [Abstract][Full Text] [Related]
12. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.
Reginster JY; Meurmans L; Zegels B; Rovati LC; Minne HW; Giacovelli G; Taquet AN; Setnikar I; Collette J; Gosset C
Ann Intern Med; 1998 Jul; 129(1):1-8. PubMed ID: 9652994
[TBL] [Abstract][Full Text] [Related]
13. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
Watts NB; Geusens P; Barton IP; Felsenberg D
J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
[TBL] [Abstract][Full Text] [Related]
14. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
15. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
[TBL] [Abstract][Full Text] [Related]
16. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
17. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
[TBL] [Abstract][Full Text] [Related]
18. Alendronate for fracture prevention in postmenopause.
Holder KK; Kerley SS
Am Fam Physician; 2008 Sep; 78(5):579-81. PubMed ID: 18788232
[TBL] [Abstract][Full Text] [Related]
19. Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women.
Papadimitropoulos E; Wells G; Shea B; Gillespie W; Weaver B; Zytaruk N; Cranney A; Adachi J; Tugwell P; Josse R; Greenwood C; Guyatt G;
Endocr Rev; 2002 Aug; 23(4):560-9. PubMed ID: 12202471
[TBL] [Abstract][Full Text] [Related]
20. Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis.
Cranney A; Tugwell P; Zytaruk N; Robinson V; Weaver B; Shea B; Wells G; Adachi J; Waldegger L; Guyatt G;
Endocr Rev; 2002 Aug; 23(4):540-51. PubMed ID: 12202469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
